Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Pageaux GP, Nzinga CL, Ganne N, Ganne N. Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis. BMC Infect Dis [Internet]. 2022;22(1):94. https://doi.org/10.1186/s12879-022-07076-0

Publication Type:

Journal Article

Authors:

Pageaux, GP; Nzinga, CL; Ganne, N; et al

Source:

BMC Infect Dis, Volume 22, Issue 1, p.94 (2022)

URL:

https://doi.org/10.1186/s12879-022-07076-0

Keywords:

Decompensated Cirrhosis, Direst-acting antiviral agents, hepatitis C virus, hepatocellular carcinoma, Survival, Sustained virological response

Cited On:

Patients With Decompensated Cirrhosis

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/35086481/

Export Citation:

RIS Format

Top